Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: 2025 Eurostat Trade Data and Economic Impact Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: 2025 Eurostat Trade Data and Economic Impact
Priya Life Science Clinical trial register
TrackersDrugsComparisonsAPI
Trackers› Clinical trials› Kōriyama
Clinical trial register · Japan

Clinical Trials in Kōriyama, 2026

Every study on the ClinicalTrials.gov registry that lists a site in Japan and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage — all 2516 matching records held by the registry are in this view. Synced 12 Nov 2026, 03:19 UTC
2516
Studies in scope
all four open statuses
1285
Recruiting now
open to new participants
352
Lead sponsors
across recruiting studies
Top sites
Fukuoka 557 Nagoya 513 Sapporo 400 Tokyo 375 Osaka 354
Narrow the registerReset
Recruitment status
Phase
Lead sponsor
Sanofi4 Karuna Therapeutics, Inc., a Bristol Myers Squibb company2 Eli Lilly and Company2 OrganTech, Inc.1 argenx1 Kyowa Kirin Co., Ltd.1 AgNovos Healthcare, LLC1
Site location
Fukuoka557 Nagoya513 Sapporo400 Tokyo375 Osaka354 Chiba328 Kashiwa317 Yokohama272 Kobe239 Kyoto231 Hiroshima224 Sendai207 Chūōku202 Matsuyama172 Bunkyō City171 Kanazawa149 Kumamoto147 Okayama133 Kashiwa-shi132 Niigata120 Fukushima114 Kagoshima107 Kanagawa105 Aichi104 Gifu103 Show all 938
All 938 locations
Target enrolment
to

Trials with a site in Kōriyama

12 of 2516 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Sites in Japan
Start
Not yet open
Eli Lilly and Company
Phase 3
3,000
Hamadayama, Suginami-ku, Himeji, Kisarazu, Kōriyama, Kumamoto, Kurume, Osaka, Shinjyuku
2026-12
Recruiting
Sanofi
Phase 3
751
Bunkyō City, Chikushino-shi, Hachiōji, Kagoshima, Kamakura, Kashiwa, Kobe, Kōriyama
2026-01-16
Recruiting
Sanofi
Phase 3
160
Kōriyama, Sapporo, Yahaba, Higashi-Matsuyama, Kodaira, Kyoto, Tokyo
2026-01-14
Recruiting
Eli Lilly and Company
Phase 3
150
Abeno, Iruma, Kawasaki, Kofu, Kōriyama, Kumamoto, Nagano, Naka
2026-01-12
Recruiting
A Study to Assess the Efficacy and Safety of Empasiprubart in Adults With CIDP
NCT07091630Chronic Inflammatory Demyelinating Polyneuropathy, CIDP, Chronic Inflammatory Demyelinating Polyradiculoneuropathy
DrugEmpasiprubart
argenx
Phase 3
160
Bunkyō-Ku, Hiroshima, Kōriyama, Saga
2025-09-16
Recruiting
Efficacy and Safety Evaluation Study of Implants With Periodontal Ligament
NCT07302581Tooth Extraction, Tooth Fractures, Dental Caries, Tooth Dislocation
OrganTech, Inc.
Not applicable
6
Kōriyama, Minato-Ku
2025-06-20
Recruiting
Karuna Therapeutics, Inc., a Bristol Myers Squibb company
Phase 3
406
Iizuka, Kōriyama, Sapporo, Himeji-Shi, Toride-shi, Takamatsu, Hadano, Kawasaki-Shi
2024-09-26
Active, closed
Kyowa Kirin Co., Ltd.
Phase 2
185
Nagakute, Nagoya, Sakura, Kurume, Kōriyama, Sapporo, Kobe, Mito
2024-01-09
Active, closed
Sanofi
Phase 3
943
Kōriyama, Asahikawa, Himeji, Sagamihara, Higashi-Matsuyama, Kodaira, Chiba, Fukuoka
2023-12-27
Active, closed
Sanofi
Phase 3
1,655
Kōriyama, Asahikawa, Sapporo, Yahaba, Sagamihara, Higashi-Matsuyama, Kodaira, Tachikawa
2023-12-13
Recruiting
Karuna Therapeutics, Inc., a Bristol Myers Squibb company
Phase 3
1,000
Iizuka, Kōriyama, Sapporo, Himeji-Shi, Toride-shi, Takamatsu, Hadano, Kawasaki-Shi
2023-07-11
Recruiting
RESTORE - Study of AGN1 LOEP to Prevent Secondary Hip Fractures
NCT04796350Fragility Fracture, Hip Fractures, Osteoporosis
AgNovos Healthcare, LLC
Not applicable
2,400
Akita, Kōriyama, Nishinomiya, Marugame, Kawasaki, Kochi, Okayama, Izunokuni
2021-04-24
Rows per page Showing 1–12 of 12
1
Cite this view

Priya Life Science (2026). Clinical trial register: studies with a Japanese investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 12 November 2026. https://priyalifescience.com/clinical-trials-japan/city/k-riyama

Query this register directly
GET /api/trials?country=in&status=recruiting&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every study on the registry that lists at least one investigative site in Japan and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 2,516 studies in total at the last sync on 12 Nov 2026, 03:19 UTC. The full list can be downloaded as CSV or queried as JSON through the register API.

This page shows the 12 of those studies with a site in Kōriyama.

How many clinical trials are recruiting in Kōriyama?

8 of the 12 studies on this page are recruiting new participants as of the 12 Nov 2026, 03:19 UTC sync. A further 1 have not yet opened recruitment, 3 are active but closed to new participants, and 0 are enrolling by invitation only. Eligibility for any study is decided by its study team.

Summary by phase

Studies by phase (Kōriyama), 12 studies
PhaseStudiesRecruitingShare
Phase 39675%
Not applicable2216.7%
Phase 2108.3%

Most active sponsors

Lead sponsors with the most studies (Kōriyama)
Lead sponsorStudiesRecruiting
Sanofi42
Eli Lilly and Company21
Karuna Therapeutics, Inc., a Bristol Myers Squibb company22
AgNovos Healthcare, LLC11
argenx11
Kyowa Kirin Co., Ltd.10
OrganTech, Inc.11
→

Other trial registries in Japan

This register lists Japan studies from ClinicalTrials.gov. Many studies in Japan are registered only in a national registry. We do not copy those records; search them directly:

  • jRCT (Japan Registry of Clinical Trials) — run by the Ministry of Health, Labour and Welfare; trials under Japan's Clinical Trials Act and other clinical research
  • UMIN-CTR — run by the University of Tokyo Hospital's UMIN Center; many academic and investigator-led studies
Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and China registers.